ClinVar Genomic variation as it relates to human health
NM_020975.6(RET):c.2298G>A (p.Pro766=)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance(1); Benign(1); Likely benign(7)
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_020975.6(RET):c.2298G>A (p.Pro766=)
Variation ID: 220687 Accession: VCV000220687.28
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 10q11.21 10: 43118386 (GRCh38) [ NCBI UCSC ] 10: 43613834 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jan 6, 2017 Oct 20, 2024 Jan 29, 2024 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_020975.6:c.2298G>A MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_066124.1:p.Pro766= synonymous NM_000323.2:c.2298G>A NP_000314.1:p.Pro766= synonymous NM_001355216.2:c.1536G>A NP_001342145.1:p.Pro512= synonymous NM_001406743.1:c.2298G>A NP_001393672.1:p.Pro766= synonymous NM_001406744.1:c.2298G>A NP_001393673.1:p.Pro766= synonymous NM_001406759.1:c.2298G>A NP_001393688.1:p.Pro766= synonymous NM_001406760.1:c.2298G>A NP_001393689.1:p.Pro766= synonymous NM_001406761.1:c.2169G>A NP_001393690.1:p.Pro723= synonymous NM_001406762.1:c.2169G>A NP_001393691.1:p.Pro723= synonymous NM_001406763.1:c.2163G>A NP_001393692.1:p.Pro721= synonymous NM_001406764.1:c.2169G>A NP_001393693.1:p.Pro723= synonymous NM_001406765.1:c.2163G>A NP_001393694.1:p.Pro721= synonymous NM_001406766.1:c.2010G>A NP_001393695.1:p.Pro670= synonymous NM_001406767.1:c.2010G>A NP_001393696.1:p.Pro670= synonymous NM_001406768.1:c.2034G>A NP_001393697.1:p.Pro678= synonymous NM_001406769.1:c.1902G>A NP_001393698.1:p.Pro634= synonymous NM_001406770.1:c.2010G>A NP_001393699.1:p.Pro670= synonymous NM_001406771.1:c.1860G>A NP_001393700.1:p.Pro620= synonymous NM_001406772.1:c.1902G>A NP_001393701.1:p.Pro634= synonymous NM_001406773.1:c.1860G>A NP_001393702.1:p.Pro620= synonymous NM_001406774.1:c.1773G>A NP_001393703.1:p.Pro591= synonymous NM_001406775.1:c.1572G>A NP_001393704.1:p.Pro524= synonymous NM_001406776.1:c.1572G>A NP_001393705.1:p.Pro524= synonymous NM_001406777.1:c.1572G>A NP_001393706.1:p.Pro524= synonymous NM_001406778.1:c.1572G>A NP_001393707.1:p.Pro524= synonymous NM_001406779.1:c.1401G>A NP_001393708.1:p.Pro467= synonymous NM_001406780.1:c.1401G>A NP_001393709.1:p.Pro467= synonymous NM_001406781.1:c.1401G>A NP_001393710.1:p.Pro467= synonymous NM_001406782.1:c.1401G>A NP_001393711.1:p.Pro467= synonymous NM_001406783.1:c.1272G>A NP_001393712.1:p.Pro424= synonymous NM_001406784.1:c.1308G>A NP_001393713.1:p.Pro436= synonymous NM_001406785.1:c.1281G>A NP_001393714.1:p.Pro427= synonymous NM_001406786.1:c.1272G>A NP_001393715.1:p.Pro424= synonymous NM_001406787.1:c.1266G>A NP_001393716.1:p.Pro422= synonymous NM_001406788.1:c.1113G>A NP_001393717.1:p.Pro371= synonymous NM_001406789.1:c.1113G>A NP_001393718.1:p.Pro371= synonymous NM_001406790.1:c.1113G>A NP_001393719.1:p.Pro371= synonymous NM_001406791.1:c.993G>A NP_001393720.1:p.Pro331= synonymous NM_001406792.1:c.849G>A NP_001393721.1:p.Pro283= synonymous NM_001406793.1:c.849G>A NP_001393722.1:p.Pro283= synonymous NM_001406794.1:c.849G>A NP_001393723.1:p.Pro283= synonymous NM_020629.2:c.2298G>A NP_065680.1:p.Pro766= synonymous NM_020630.7:c.2298G>A NP_065681.1:p.Pro766= synonymous NC_000010.11:g.43118386G>A NC_000010.10:g.43613834G>A NG_007489.1:g.46318G>A LRG_518:g.46318G>A LRG_518t1:c.2298G>A LRG_518p1:p.Pro766= LRG_518t2:c.2298G>A LRG_518p2:p.Pro766= - Protein change
- -
- Other names
- -
- Canonical SPDI
- NC_000010.11:43118385:G:A
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
-
The Genome Aggregation Database (gnomAD) 0.00003
NHLBI Exome Sequencing Project (ESP) Exome Variant Server 0.00008
Trans-Omics for Precision Medicine (TOPMed) 0.00009
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
RET | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
3595 | 3717 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely benign (1) |
criteria provided, single submitter
|
Jan 29, 2024 | RCV000205891.14 | |
Benign/Likely benign (2) |
criteria provided, multiple submitters, no conflicts
|
Apr 18, 2023 | RCV000410239.4 | |
Likely benign (2) |
criteria provided, multiple submitters, no conflicts
|
Jul 7, 2023 | RCV000412216.4 | |
Likely benign (2) |
criteria provided, multiple submitters, no conflicts
|
Oct 16, 2023 | RCV001015052.4 | |
Conflicting interpretations of pathogenicity (2) |
criteria provided, conflicting classifications
|
May 1, 2023 | RCV002225506.14 | |
RET-related disorder
|
Likely benign (1) |
no assertion criteria provided
|
Mar 21, 2024 | RCV004739599.1 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely benign
(Jan 07, 2022)
|
criteria provided, single submitter
Method: curation
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Sema4, Sema4
Accession: SCV002529971.1
First in ClinVar: Jun 24, 2022 Last updated: Jun 24, 2022 |
|
|
Likely benign
(Sep 12, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia type 2B
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000489995.2
First in ClinVar: Jan 06, 2017 Last updated: Dec 24, 2022 |
|
|
Likely benign
(Sep 12, 2016)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia type 2A
Affected status: unknown
Allele origin:
unknown
|
Counsyl
Accession: SCV000489996.2
First in ClinVar: Jan 06, 2017 Last updated: Dec 24, 2022 |
|
|
Uncertain significance
(Oct 25, 2021)
|
criteria provided, single submitter
Method: clinical testing
|
Not Provided
Affected status: yes
Allele origin:
germline
|
GeneDx
Accession: SCV002504181.2
First in ClinVar: Apr 29, 2022 Last updated: Mar 04, 2023 |
Comment:
In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change … (more)
In-silico analysis is inconclusive as to whether the variant alters gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Observed in an individual with Hirschsprung disease (Jannot et al., 2012); This variant is associated with the following publications: (PMID: 28873162, 22395866) (less)
|
|
Likely benign
(Jul 07, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia type 2B
Affected status: yes
Allele origin:
germline
|
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Accession: SCV004017355.1
First in ClinVar: Jul 29, 2023 Last updated: Jul 29, 2023 |
|
|
Likely benign
(Jan 29, 2024)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia, type 2
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV000261436.10
First in ClinVar: Feb 02, 2016 Last updated: Feb 28, 2024 |
|
|
Likely benign
(Oct 16, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV001175841.4
First in ClinVar: Mar 16, 2020 Last updated: May 01, 2024 |
Comment:
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of … (more)
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. (less)
|
|
Benign
(Apr 18, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
Multiple endocrine neoplasia type 2A
Affected status: unknown
Allele origin:
unknown
|
Myriad Genetics, Inc.
Accession: SCV004018482.1
First in ClinVar: Jul 29, 2023 Last updated: Jul 29, 2023 |
Comment:
This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing.
|
|
Likely benign
(May 01, 2023)
|
criteria provided, single submitter
Method: clinical testing
|
not provided
Affected status: yes
Allele origin:
germline
|
CeGaT Center for Human Genetics Tuebingen
Accession: SCV004127604.10
First in ClinVar: Nov 20, 2023 Last updated: Oct 20, 2024 |
Comment:
RET: BP4, BP7
Number of individuals with the variant: 1
|
|
Likely benign
(Mar 21, 2024)
|
no assertion criteria provided
Method: clinical testing
|
RET-related condition
Affected status: unknown
Allele origin:
germline
|
PreventionGenetics, part of Exact Sciences
Accession: SCV005345881.1
First in ClinVar: Oct 08, 2024 Last updated: Oct 08, 2024 |
Comment:
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Male and female differential reproductive rate could explain parental transmission asymmetry of mutation origin in Hirschsprung disease. | Jannot AS | European journal of human genetics : EJHG | 2012 | PMID: 22395866 |
Text-mined citations for rs140658743 ...
HelpRecord last updated Oct 20, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.